Skip to content
Investing in Cures for Multiple Sclerosis episode artwork

Sep 9, 2008 12 min

Investing in Cures for Multiple Sclerosis

from Clinician's Roundtable

Host: Bruce Bloom, DDS, JD Guest: Timothy Coetzee, PhD Through a venture philanthropy called Fast Forward, LLC the National Multiple Sclerosis Society plans to deploy 1.5 to 2 million dollars in the next 18 months as seed funding to biotech companies on the path towards cures for Multiple Sclerosis. Our guest, Timothy Coetzee executive director of Fast Forward, LLC joins host Dr. Bruce Bloom to talk about genomics, novel immune system therapies and other hopeful possibilities leading towards cures for multiple sclerosis. Interesting also is the process by which the biotech companies are evaluated and followed after an investment is made.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Investing in Cures for Multiple Sclerosis

0:00 12:59

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Clinician's Roundtable?

This episode is 12 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on September 9, 2008.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.